Completed
Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage
What is being collected
Data Collection
Collected from today forward - ProspectiveDNA Samples
Who is being recruted
Brain Diseases+10
+ Cardiovascular Diseases
+ Central Nervous System Diseases
From 18 to 89 Years
+7 Eligibility Criteria
How is the trial designed
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Observational
Study Start: April 2011
Summary
Principal SponsorState University of New York - Upstate Medical University
Last updated: November 20, 2014
Sourced from a government-validated database.Claim as a partner
Study start date: April 1, 2011
Actual date on which the first participant was enrolled.The purpose of this study is to determine the role of Proteomics and Metallomics in Cerebral Vasospasm following Subarachnoid Hemorrhage
Principal SponsorState University of New York - Upstate Medical University
Last updated: November 20, 2014
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
40 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
These studies compare people who have a disease (cases) with those who don't (controls). The goal is to look back at previous exposures or risk factors to identify what might have contributed to the disease.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 18 to 89 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Brain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesCerebrovascular DisordersHemorrhageNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesIntracranial HemorrhagesHydrocephalusSubarachnoid HemorrhageVasospasm, Intracranial
Criteria
4 inclusion criteria required to participate
Control (non - hemorrhagic) group - CSF collected from patients with posterior fossa tumor or stroke with EVD in place for the management of hydrocephalus
Non traumatic SAH documented by CT scan
Patient with SAH who would need external ventricular drain (EVD) for the management of hydrocephalus
Patients with normal pressure Hydrocephalus that require an external drain
3 exclusion criteria prevent from participating
Age > 89 years or < 18 years
Recent infection within last 1 month of presentation- can increase inflammatory markers
Recent surgery or acute myocardial infarction within last 1 month of presentation
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
State University of New York Upstate Medical University
Syracuse, United StatesOpen State University of New York Upstate Medical University in Google MapsCompletedOne Study Center